Provided by Tiger Trade Technology Pte. Ltd.

Biogen

225.88
-1.1900-0.52%
Post-market: 225.880.00000.00%19:30 EDT
Volume:1.55M
Turnover:352.50M
Market Cap:33.35B
PE:40.12
High:229.36
Open:227.23
Low:225.51
Close:227.07
52wk High:230.49
52wk Low:138.00
Shares:147.64M
Float Shares:147.31M
Volume Ratio:1.30
T/O Rate:1.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.63
EPS(LYR):8.79
ROE:4.58%
ROA:5.21%
PB:1.77
PE(LYR):25.70

Loading ...

U.S. Research Roundup-Broadcom, Deere & Co, Snowflake

Reuters
·
Sep 03

Biogen : Piper Sandler Raises Target Price to $245 from $225

THOMSON REUTERS
·
Sep 03

Biogen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 03

Stoke Therapeutics and Biogen Announce Presentations of Clinical Data from Studies of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16TH European Epilepsy Congress (Eec)

THOMSON REUTERS
·
Sep 01

Stoke Therapeutics and Biogen Announce Presentations of Clinical Data from Studies of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)

GlobeNewswire
·
Sep 01

Biogen, Eisai announce positive recommendation for Leqembi in Canada

TIPRANKS
·
Sep 01

Eisai: Canada's Drug Agency Issues Final Positive Recommendation for Leqembi Reimbursement in Early Alzheimer's Disease

THOMSON REUTERS
·
Sep 01

Biogen Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 29

Biogen CEO Viehbacher to Speak at Morgan Stanley Global Healthcare Conference

Reuters
·
Aug 28

Biogen CFO Robin Kramer to Join Wells Fargo Healthcare Conference Fireside Chat

Reuters
·
Aug 26

Biogen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 26

Biogen is Maintained at Outperform by RBC Capital

Dow Jones
·
Aug 25

Sector Update: Healthcare Stocks Edge Higher Premarket Tuesday

MT Newswires Live
·
Aug 25

Veeva Systems Secures Biogen, Regeneron Pharmaceuticals as New Vault CRM Clients

MT Newswires Live
·
Aug 25

Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (GEHC), Biogen (BIIB) and BeOne Medicines (ONC)

TIPRANKS
·
Aug 25

RBC Capital Adjusts Price Target on Biogen to $260 From $240

MT Newswires Live
·
Aug 25

Biogen, Eisai's LEQEMBI IQLIK Now Available in US for Early Alzheimer's Disease

MT Newswires Live
·
Aug 24

Eisai, Biogen announces once weekly lecanemab-irmb availability in the U.S.

TIPRANKS
·
Aug 24

Eisai Co., Ltd.: Leqembi Iqlik (Lecanemab-Irmb) Autoinjector for Initiation of Therapy NOW Available in U.S. for Early Alzheimer's Disease

THOMSON REUTERS
·
Aug 24

How Investors Are Reacting To Biogen (BIIB) Raising EPS Guidance On Late-Stage Drug Trial Milestones

Simply Wall St.
·
Aug 23